Andreas W.

Andreas W. is a seasoned biotech executive with extensive experience in leadership roles across various organizations since 2005, including Breakthrough CMC and Development. Currently serving as Principal and Executive Advisor at Woppmann Consulting, LLC, Andreas specializes in executive strategy and global operations consulting for biotechnology and pharmaceutical companies. Key roles include Principal Consultant at AI Proteins, focusing on therapeutic protein development; Principal Consultant at Lubris BioPharma, aiding in the development of rh-Lubricin; and prior work with the Sabin Vaccine Institute on vaccine development. Also notable are contributions as EVP/CTO at Syntimmune leading to a significant acquisition, and as Vice President at ARIAD Pharmaceuticals during a critical growth phase. Academically, Andreas holds advanced degrees in Molecular Neurobiology and related fields from prestigious institutions such as the University of Southern California and the Max-Planck Institute, complemented by significant early education focusing on life sciences.